Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 4 | 2024 | 5263 | 0.450 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2024 | 1636 | 0.430 |
Why?
|
| Inhibitor of Apoptosis Proteins | 3 | 2023 | 215 | 0.380 |
Why?
|
| Melanoma | 4 | 2023 | 5511 | 0.360 |
Why?
|
| Melanoma, Experimental | 3 | 2018 | 561 | 0.280 |
Why?
|
| NF-kappa B | 3 | 2024 | 2499 | 0.270 |
Why?
|
| Natural Killer T-Cells | 2 | 2019 | 316 | 0.260 |
Why?
|
| Interleukin-2 | 3 | 2022 | 1904 | 0.240 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2024 | 4479 | 0.230 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2021 | 1366 | 0.230 |
Why?
|
| Aminopyridines | 2 | 2023 | 542 | 0.210 |
Why?
|
| Cytokines | 4 | 2022 | 7323 | 0.200 |
Why?
|
| Anus Neoplasms | 1 | 2024 | 332 | 0.180 |
Why?
|
| Purines | 1 | 2023 | 594 | 0.170 |
Why?
|
| Phagocytes | 1 | 2021 | 297 | 0.170 |
Why?
|
| Peyer's Patches | 1 | 2019 | 121 | 0.170 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2021 | 168 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2021 | 323 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2020 | 431 | 0.160 |
Why?
|
| Immunoglobulin Fragments | 1 | 2018 | 84 | 0.160 |
Why?
|
| Interleukin-15 | 1 | 2019 | 184 | 0.160 |
Why?
|
| Molecular Mimicry | 1 | 2019 | 201 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2021 | 539 | 0.150 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2019 | 291 | 0.150 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2019 | 573 | 0.150 |
Why?
|
| Immunotherapy | 4 | 2022 | 4446 | 0.150 |
Why?
|
| Interferon-gamma | 2 | 2023 | 3207 | 0.150 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2024 | 1821 | 0.140 |
Why?
|
| Speech Perception | 1 | 2021 | 490 | 0.140 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2018 | 279 | 0.140 |
Why?
|
| Speech | 1 | 2021 | 541 | 0.140 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2020 | 1475 | 0.130 |
Why?
|
| Mice | 14 | 2023 | 81201 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2024 | 2540 | 0.120 |
Why?
|
| Receptors, Immunologic | 1 | 2020 | 1423 | 0.120 |
Why?
|
| Antigens, Neoplasm | 2 | 2020 | 1988 | 0.120 |
Why?
|
| Drug Design | 1 | 2019 | 1076 | 0.110 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 3590 | 0.110 |
Why?
|
| Papillomavirus Infections | 1 | 2024 | 1587 | 0.100 |
Why?
|
| Animals | 16 | 2023 | 168768 | 0.100 |
Why?
|
| Immunoglobulin G | 2 | 2019 | 4561 | 0.090 |
Why?
|
| T-Lymphocytes | 3 | 2023 | 10183 | 0.090 |
Why?
|
| Cell Line, Tumor | 6 | 2023 | 16690 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2024 | 4034 | 0.080 |
Why?
|
| Neoplasms | 3 | 2023 | 21696 | 0.080 |
Why?
|
| Peptides | 1 | 2020 | 4410 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 5534 | 0.060 |
Why?
|
| Transforming Growth Factors | 1 | 2023 | 76 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9445 | 0.050 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 18034 | 0.050 |
Why?
|
| Perforin | 1 | 2023 | 168 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 21833 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2023 | 580 | 0.050 |
Why?
|
| Camelids, New World | 1 | 2020 | 20 | 0.050 |
Why?
|
| Albumins | 1 | 2023 | 568 | 0.050 |
Why?
|
| Enteritis | 1 | 2021 | 165 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 13693 | 0.040 |
Why?
|
| Gastritis | 1 | 2021 | 196 | 0.040 |
Why?
|
| Vaccines, Subunit | 1 | 2020 | 168 | 0.040 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2019 | 64 | 0.040 |
Why?
|
| Breast Neoplasms, Male | 1 | 2021 | 210 | 0.040 |
Why?
|
| Galactosylceramides | 1 | 2019 | 92 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2019 | 140 | 0.040 |
Why?
|
| Carcinoma, Small Cell | 1 | 2020 | 420 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2020 | 5524 | 0.040 |
Why?
|
| Humans | 14 | 2024 | 744366 | 0.040 |
Why?
|
| Colonic Neoplasms | 2 | 2020 | 2542 | 0.040 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2019 | 310 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2020 | 694 | 0.040 |
Why?
|
| Semantics | 1 | 2021 | 585 | 0.040 |
Why?
|
| Eosinophilia | 1 | 2021 | 541 | 0.040 |
Why?
|
| Protein Stability | 1 | 2019 | 556 | 0.040 |
Why?
|
| Immunity | 1 | 2023 | 1014 | 0.040 |
Why?
|
| Eosinophils | 1 | 2021 | 955 | 0.040 |
Why?
|
| T-Box Domain Proteins | 1 | 2019 | 471 | 0.040 |
Why?
|
| Benzimidazoles | 1 | 2021 | 850 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2023 | 1708 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2020 | 1794 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2019 | 1147 | 0.030 |
Why?
|
| Autoantigens | 1 | 2020 | 892 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2017 | 813 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 2007 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2021 | 1056 | 0.030 |
Why?
|
| Apoptosis | 2 | 2023 | 9724 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2019 | 2012 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 20824 | 0.030 |
Why?
|
| Ligands | 1 | 2020 | 3282 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2018 | 1189 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2021 | 23404 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2017 | 1267 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2019 | 19233 | 0.030 |
Why?
|
| Cancer Vaccines | 1 | 2020 | 1023 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1375 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3554 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2017 | 1539 | 0.030 |
Why?
|
| Language | 1 | 2021 | 1471 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4208 | 0.020 |
Why?
|
| Piperazines | 1 | 2021 | 2488 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 6621 | 0.020 |
Why?
|
| Binding Sites | 1 | 2019 | 6111 | 0.020 |
Why?
|
| DNA | 1 | 2024 | 7294 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2020 | 8436 | 0.020 |
Why?
|
| Pyridines | 1 | 2021 | 2825 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2019 | 5451 | 0.020 |
Why?
|
| Anemia | 1 | 2017 | 1503 | 0.020 |
Why?
|
| Cell Survival | 1 | 2018 | 5882 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4851 | 0.020 |
Why?
|
| Vaccination | 1 | 2019 | 3279 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 13814 | 0.020 |
Why?
|
| Macrophages | 1 | 2021 | 5660 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2725 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 9735 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2021 | 6151 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2019 | 6194 | 0.020 |
Why?
|
| Disease Progression | 1 | 2020 | 13286 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2017 | 14561 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11525 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11486 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 9274 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2024 | 53290 | 0.010 |
Why?
|
| Female | 3 | 2021 | 380193 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2024 | 77460 | 0.010 |
Why?
|
| Brain | 1 | 2021 | 26388 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 13104 | 0.010 |
Why?
|
| Male | 2 | 2021 | 350115 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 163288 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 213390 | 0.000 |
Why?
|
| Adult | 1 | 2021 | 214052 | 0.000 |
Why?
|
Concepts
(128)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(51)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_